[1]徐 圣,朱海东,陈 荔,等.经皮穿刺引流术在细菌性肝脓肿治疗中的作用 [J].介入放射学杂志,2018,27(02):181-185.
 XU Sheng,ZHU Haidong,CHEN Li,et al.The clinical application of percutaneous puncturing drainage in treating bacterial liver abscess[J].journal interventional radiology,2018,27(02):181-185.
点击复制

经皮穿刺引流术在细菌性肝脓肿治疗中的作用


()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年02期
页码:
181-185
栏目:
综述
出版日期:
2018-02-25

文章信息/Info

Title:
The clinical application of percutaneous puncturing drainage in treating bacterial liver abscess
作者:
徐 圣 朱海东 陈 荔 周海峰 滕皋军
Author(s):
XU Sheng ZHU Haidong CHEN Li ZHOU Haifeng TENG Gaojun
Medical School, Southeast University, Nanjing, Jiangsu Province 210009, China
关键词:
【关键词】 经皮穿刺引流术 细菌性肝脓肿 经皮穿刺导管引流术 抗生素 临床无效
文献标志码:
A
摘要:
【摘要】 细菌性肝脓肿是一种罕见又会危及生命的疾病,近年来发病率有所升高。就治疗而言,经皮穿刺引流术联合抗生素已成为细菌性肝脓肿的一线治疗手段,外科手术多用于介入引流无效或肝脓肿合并有外科适应证的腹部疾病。作为常用的两种介入引流术,经皮穿刺导管引流术和经皮穿刺细针抽吸术广泛应用于细菌性肝脓肿的治疗,并以前者居多。尽管细菌性肝脓肿的预后已明显改善,但其仍有一定的致死率,治疗指南仍未达成共识,经皮穿刺引流术的适应证仍存在争议。本文复习国内外文献,就经皮穿刺引流术在细菌性肝脓肿治疗中的发展历程、疗效、预后、抗生素的使用原则、与外科对比及治疗适应证探讨进行综述,以指导临床实践。

参考文献/References:

[1] Jepsen P, Vilstrup H, Schonheyder HC, et al. A nationwide study of the incidence and 30- day mortality rate of pyogenic liver abscess in Denmark, 1977- 2002[J]. Aliment Pharmacol Ther, 2005, 21: 1185- 1188.
[2] Meddings L, Myers RP, Hubbard J, et al. A population- based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends[J]. Am J Gastroenterol, 2010, 105: 117- 124.
[3] Kaplan GG, Gregson DB, Laupland KB. Population- based study of the epidemiology of and the risk factors for pyogenic liver abscess[J]. Clin Gastroenterol Hepatol, 2004, 2: 1032- 1038.
[4] Tsai FC, Huang YT, Chang LY, et al. Pyogenic liver abscess as endemic disease, Taiwan[J]. Emerg Infect Dis, 2008, 14: 1592- 1600.
[5] Verlenden WL 3rd, Frey CF. Management of liver abscess[J]. Am J Surg, 1980, 140: 53- 59.
[6] Chen YC, Lin CH, Chang SN, et al. Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000- 2011[J]. J Microbiol Immunol Infect, 2014, 49: 646- 653.
[7] Giorgio A, Tarantino L, Mariniello N, et al. Pyogenic liver abscesses: 13 years of experience in percutaneous needle aspiration with US guidance[J]. Radiology, 1995, 195: 122- 124.
[8] McFadzean AJ, Chang KP, Wong CC. Solitary pyogenic abscess of the liver treated by closed aspiration and antibiotics: a report of 14 consecutive cases with recovery[J]. Br J Surg, 1953, 41: 141- 152.
[9] Smith EH, Bartrum RJ. Ultrasonically guided percutaneous aspiration of abscesses[J]. Am J Roentgenol Radium Ther Nucl Med, 1974, 122: 308- 312.
[10] Van der Spek P, Peters O, Claes H, et al. Percutaneous catheter drainage of solitary pyogenic liver abscess[J]. Acta Clin Belg, 1984, 39: 363- 367.
[11] 梁国庆, 黄 韬, 陆立平. B超引导下经皮肝穿刺置管引流治疗肝脓肿的临床应用[J]. 中华肝胆外科杂志, 2007, 13: 206- 207.
[12] 尹 君, 唐启耀, 罗 军. 细菌性肝脓肿的经皮穿刺引流治疗[J]. 介入放射学杂志, 2014, 23: 815- 818.
[13] Ahmed S, Chia CL, Junnarkar SP, et al. Percutaneous drainage for giant pyogenic liver abscess: is it safe and sufficient?[J]. Am J Surg, 2016, 211: 95- 101.
[14] Rajak CL, Gupta S, Jain S, et al. Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage[J]. AJR Am J Roentgenol, 1998, 170: 1035- 1039.
[15] Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess[J]. AJR Am J Roentgenol, 2007, 189: W138- W142.
[16] Yu SC, Ho SS, Lau WY, et al. Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration[J]. Hepatology, 2004, 39: 932- 938.
[17] Singh O, Gupta S, Moses S, et al. Comparative study of catheter drainage and needle aspiration in management of large liver abscesses[J]. Indian J Gastroenterol, 2009, 28: 88- 92.
[18] 张 炜, 秦天霞, 路永光. 超声引导下介入治疗肝脓肿的临床应用[J]. 中华全科医师杂志, 2013, 12: 311.
[19] Chung DR, Lee SS, Lee HR, et al. Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea[J]. J Infect, 2007, 54: 578- 583.
[20] Wang JH, Liu YC, Lee SS, et al. Primary liver abscess due to Klebsiella pneumoniae in Taiwan[J]. Clin Infect Dis, 1998, 26: 1434- 1438.
[21] Yang CC, Yen CH, Ho MW, et al. Comparison of pyogenic liver abscess caused by non- Klebsiella pneumoniae and Klebsiella pneumoniae[J]. J Microbiol Immunol Infect, 2004, 37: 176- 184.
[22] 赵小芹, 蒋艳敏, 朱晓巍, 等. 糖尿病合并细菌性肝脓肿的临床特征分析[J]. 中华内分泌代谢杂志, 2012, 28: 48- 50.
[23] Lin YT, Wang FD, Wu PF, et al. Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics[J]. BMC Infect Dis, 2013, 13: 56.
[24] Han D, Leyva CA, Matheson D, et al. Immune profiling by multiple gene expression analysis in patients at- risk and with type 1 diabetes[J]. Clin Immunol, 2011, 139: 290- 301.
[25] Noel RA, Braun DK, Patterson RE, et al. Increased risk of acute pancreatitis and biliary disease observed in patients with type 2 diabetes: a retrospective cohort study[J]. Diabetes Care, 2009, 32: 834- 838.
[26] Lai KC, Cheng KS, Jeng LB, et al. Factors associated with treatment failure of percutaneous catheter drainage for pyogenic liver abscess in patients with hepatobiliary- pancreatic cancer[J]. Am J Surg, 2013, 205: 52- 57.
[27] Tan YM, Chung AY, Chow PK, et al. An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm[J]. Ann Surg, 2005, 241: 485- 490.
[28] Mezhir JJ, Fong Y, Jacks LM, et al. Current management of pyogenic liver abscess: surgery is now second- line treatment[J]. J Am Coll Surg, 2010, 210: 975- 983.
[29] Liao WI, Tsai SH, Yu CY, et al. Pyogenic liver abscess treated by percutaneous catheter drainage: MDCT measurement for treatment outcome[J]. Eur J Radiol, 2012, 81: 609- 615.
[30] Lo JZ, Leow JJ, Ng PL, et al. Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses[J]. J Hepatobiliary Pancreat Sci, 2015, 22: 156- 165.
[31] Sugiyama M, Atomi Y. Pyogenic hepatic abscess with biliary communication[J]. Am J Surg, 2002, 183: 205- 208.
[32] Hope WW, Vrochides DV, Newcomb WL, et al. Optimal treatment of hepatic abscess[J]. Am Surg, 2008, 74: 178- 182.
[33] Tazawa J, Sakai Y, Maekawa S, et al. Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage[J]. Am J Gastroenterol, 1997, 92: 271- 274.
[34] 蒋 辉, 陈思瑞, 吴 泓, 等. 多房性细菌性肝脓肿手术和经皮穿刺引流的评价[J]. 中华普通外科杂志, 2008, 23: 953- 955.
[35] Liu CH, Gervais DA, Hahn PF, et al. Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome?[J]. J Vasc Interv Radiol, 2009, 20: 1059- 1065.
[36] Lardiere- Deguelte S, Ragot E, Amroun K, et al. Hepatic abscess: diagnosis and management[J]. J Visc Surg, 2015, 152: 231- 243.
[37] Barnes PF, De Cock KM, Reynolds TN, et al. A comparison of amebic and pyogenic abscess of the liver[J]. Medicine (Baltimore), 1987, 66: 472- 483.
[38] Brunetti E, Capellini R, Meloni C, et al. The value of culture of pus via percutaneous drainage under sonographic guidance in diagnosis and therapy of pyogenic liver abscess[J]. Int J Antimicrob Agents, 1995, 6: 81- 83.
[39] Chung YF, Tan YM, Lui HF, et al. Management of pyogenic liver abscesses- percutaneous or open drainage?[J]. Singapore Med J, 2007, 48: 1158- 1165.
[40] Solomkin JS, Reinhart HH, Dellinger EP, et al. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra- abdominal infections. The Intra- Abdominal Infection Study Group[J]. Ann Surg, 1996, 223: 303- 315.
[41] Ng FH, Wong WM, Wong BC, et al. Sequential intravenous/oral antibiotic vs. continuous intravenous antibiotic in the treatment of pyogenic liver abscess[J]. Aliment Pharmacol Ther, 2002, 16: 1083- 1090.
[42] Levin DC, Eschelman D, Parker L, et al. Trends in use of percutaneous versus open surgical drainage of abdominal abscesses[J]. J Am Coll Radiol, 2015, 12: 1247- 1250.
[43] Tan YM, Chee SP, Soo KC, et al. Ocular manifestations and complications of pyogenic liver abscess[J]. World J Surg, 2004, 28: 38- 42.
[44] Ferraioli G, Garlaschelli A, Zanaboni D, et al. Percutaneous and surgical treatment of pyogenic liver abscesses: observation over a 21- year period in 148 patients[J]. Dig Liver Dis, 2008, 40: 690- 696.
[45] 杜 飞, 周成明, 曹 峻, 等. 穿刺引流与手术治疗细菌性肝脓肿疗效比较[J]. 中华普通外科杂志, 2015, 30: 201- 203.
[46] Luo M, Yang XX, Tan B, et al. Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta- analysis[J]. Eur J Clin Microbiol Infect Dis, 2016, 35: 1557- 1565.
[47] 关庆斌, 谢永灿, 罗海军, 等. 细菌性肝脓肿三种不同手术方式的疗效观察[J]. 国际医药卫生导报, 2012, 18: 3552- 3555.

备注/Memo

备注/Memo:
(收稿日期:2017-03-13)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2018-02-24